Navigation Links
Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
Date:2/18/2009

been clinically used to terminate tachycardia in certain cases.

About Cordex Pharma, Inc.

Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex has a portfolio of investigational medicines, two of which are in late stages of clinical development. Cordex's ATPace is expected to enter a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical trial for the treatment of heart failure in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For further information regarding Cordex, please visit the company's website at www.cordexpharma.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statem
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
2. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
3. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
4. Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2009 Financial Results
5. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
6. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
7. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
8. WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
9. Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009
10. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
11. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Virginia (PRWEB) March 06, 2015 The ... it has awarded five-year accreditation status to seven more ... mean that another 1.3 million people can now be ... protect and promote the health of their communities. , ... and improving the health of people and communities. Across ...
(Date:3/5/2015)... Lubbock, TX (PRWEB) March 05, 2015 From ... Exchange’s 2015 Textile Sustainability Conference . These dates include ... Cocktail Reception for all Attendees , October 6: ... , October 7: Conference Day 2, ending with ... Annual Organic Cotton Round Table and other Materials Meetings , ...
(Date:3/5/2015)... In 2014, the FDA approved 44 ... the list scoring 4 drug approvals in the USA. ... FDA approved drug products, followed by oncology therapy with ... anti-PD1 and CDK inhibitors keep on attracting large-cap pharmacos. ... to treat metastatic melanoma, and at present, they are ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 The global digital PCR ... 2019, at CAGR of 7.8% from 2014 to 2019. , The ... at a CAGR of 7.8% from 2014 to 2019. Although the ... larger shares in the digital PCR (dPCR) and qPCR market the ... 10.7% in the forecast period. The growth of the digital PCR ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Shania Twain ... more than a decade. She has hinted that this will ... miss seeing her perform one last time. She has had ... this beloved country sweetheart has millions of loyal fans around the ... her native country, Canada, and on June 30th she will be ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... Morganville infant benefits from cutting-edge treatment HAZLET, N.J., May ... months old, his parents were shocked to note that Max,s ... immediately sought medical attention. The diagnosis? Plagiocephaly.Plagiocephaly can develop when ... infant carrier or crib. It can also be acquired ...
... MORRISTOWN, N.J., May 21 When Grace Helmer ... discovered her head was becoming very flat on one ... checkup, her pediatrician referred Grace to a neurosurgeon who ... of babies resting for prolonged periods in one position ...
... With the Alberta Government,s May 20th announcement of its ... completed the funding puzzle and is pleased to announce ... a leading role in genomic research.Helping Energy Extraction Become ... are naturally occurring microbes that have been hard at ...
... 21 Three HealthEast Care System hospitals have ... to settle allegations that the health care facilities ... announced today. All three hospitals are located in ... that the St. Paul-based hospitals overcharged Medicare from ...
... have found that bipolar disorder is more costly than ... coronary artery disease. These findings are based on a ... (the costs of seeing any specialist and all tests ... this review are being presented today at the Annual ...
... Inuit children have the highest rate of hospital ... new research shows that lowering risk factors though public ... health for Inuit children and lower health care costs ... by Dr. Anna Banerji, a pediatric infectious disease specialist ...
Cached Medicine News:Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of New Jersey Children 2Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of New Jersey Children 3Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of Children 2Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of Children 3Health News:Genomics for a Greener World 2Health News:Genomics for a Greener World 3Health News:Minnesota Hospitals to Pay U.S. $2.28 Million to Settle False Claims Act Allegations 2Health News:First of its kind study identifies risk factors for LRTIs in Inuit children 2
(Date:3/5/2015)... March 5, 2015 Hitachi ... generation of OASIS *    at ECR 2015 ... power will set a benchmark for patient-centric care. The ... prevent delays whilst optimizing workflow management and costs. OASIS ... and safety for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... multi-disciplinary clinical specialty, aimed at improving patient care ... individually adjust the dose of drugs for improving ...
(Date:3/5/2015)... and VANCOUVER, British Columbia , March ... 20B OTCQB: BMKDF) -- The ultimate goal in the ... is capable of detecting tumors before they become disruptive, ... development of such an assay has been the ... industry. Although many breakthrough diagnostics have been invented such ...
Breaking Medicine Technology:Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... , MUMBAI, India , Feb. 9 ... presence in India , Western and Central Eastern Europe, ... with DreamCIS Inc., a leading CRO based in Seoul, ... of experience in offering clinical research services to pharmaceutical companies, ...
... ANDOVER, Mass. , Feb. 9 Visage Imaging®, Inc., ... today John Danahy joins as General Manager North ... healthcare IT industry, Johns brings a wealth of experience to the ... where he managed the national sales organization and developed new business ...
Cached Medicine Technology:SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 2SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 3Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2
Double-ended. 12 mm bayonet shaped blade. 10 mm curved blade....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
4 mm blade. Flat handle....
Medicine Products: